ArticleCancer medicine2015

Feasibility of implementing molecular-guided therapy for the treatment of patients with relapsed or refractory neuroblastoma.

Giselle L Saulnier Sholler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.